DECAMP 1 PLUS Proposal: Prediction of Lung Cancer Using Noninvasive Biomarkers

Brief description of study

The DECAMP 1 PLUS study will expand on previous early detection studies (DECAMP 1 and 2) to improve the efficiency of the diagnostic evaluation of patients with indeterminate pulmonary nodules. This study will investigate molecular, clinical and imaging features that may distinguish benign versus malignant disease among smokers with indeterminate pulmonary nodules in both a screening (Arm 1) and an incidental (Arm 2) clinical setting.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions:
Lung Cancer, indeterminate pulmonary nodules
Age: Between 18 Years - 99 Years
Gender: All

Updated on 09 Mar 2024. Study ID: 843762

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).